These results indicate that the degree of MBD is related to the expression level of RUNX2 in MM, and the aggravation of bone destruction is accompanied by an increase in RUNX2 expression, confirming that RUNX2 is a molecule that promotes the development of MBD. Here, RUNX2 is linked to Miyoshi myopathy.